Research comparison of standard Semax vs N-Acetyl Semax Amidate (NASSA) — acetylation and amidation modifications for improved stability and potency, dose equivalence, nasal spray reconstitution, and which form is appropriate for which research goal.

Research guide to peptides with cardiovascular applications — BPC-157 nitric oxide pathway and blood pressure research, TB-500 angiogenesis and cardiac repair, thymosin beta-4 post-MI research, BNP as a biomarker vs therapeutic peptides, and heart failure peptide research.

Research comparison of the three mitochondrial-derived peptides — MOTS-c (AMPK activation), SS-31 (cardiolipin binding), and Humanin (cytoprotection/IGF-1) — with dosing protocols, combination rationale, and longevity vs performance applications.

Research guide exploring gut microbiome interactions with research peptides — BPC-157 gut healing mechanisms, LL-37 antimicrobial effects on gut pathogens, GLP-1 peptide microbiome interactions, vagus nerve signaling, and leaky gut protocols.

Research comparison of Ipamorelin (GHRP/ghrelin mimetic) vs Sermorelin (GHRH analog) — complementary mechanisms, pulse characteristics, cortisol/prolactin differences, half-life comparison, and why combining both optimizes GH release research protocols.

Research overview of myostatin inhibition — covering myostatin/GDF-8 biology, ACE-031 ACVR2B antagonist research, follistatin-344 peptide, YK-11 myostatin modulation, natural epicatechin inhibitors, and clinical muscular dystrophy applications.

Research guide to SS-31 (Elamipretide) — the Szeto-Schiller mitochondria-targeting peptide that stabilizes cardiolipin in the inner mitochondrial membrane, with Phase 2/3 heart failure trial data, dosing, and longevity applications.

Research overview of kisspeptin — the KISS1 receptor agonist that drives GnRH pulsatile release, LH/FSH/testosterone cascades, fertility research applications, and administration protocols.